We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.02B
AUM Growth
+$434M
Cap. Flow
+$190M
Cap. Flow %
6.3%
Top 10 Hldgs %
45.02%
Holding
338
New
35
Increased
173
Reduced
106
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOR icon
326
Vor Biopharma
VOR
$1.15B
$30.7K ﹤0.01%
683
-16
-2% -$660
RBBN icon
327
Ribbon Communications
RBBN
$377M
$29.1K ﹤0.01%
10,030
ISPC icon
328
iSpecimen
ISPC
$2.72M
$15.4K ﹤0.01%
39
-31
-44% -$13.5K
RGLS
329
DELISTED
Regulus Therapeutics
RGLS
$13.3K ﹤0.01%
10,420
-127
-1% -$169
XFOR icon
330
X4 Pharmaceuticals
XFOR
$375M
$12.6K ﹤0.01%
500
OTLK icon
331
Outlook Therapeutics
OTLK
$183M
$3.94K ﹤0.01%
500
BIZD icon
332
VanEck BDC Income ETF
BIZD
$1.59B
-20,054
Closed -$321K
DGRW icon
333
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
-3,215
Closed -$204K
MUJ icon
334
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$637M
-10,490
Closed -$106K
OXY icon
335
Occidental Petroleum
OXY
$56.8B
-3,601
Closed -$234K
TOTL icon
336
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.09B
-7,339
Closed -$284K
VIGI icon
337
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
-2,944
Closed -$210K
XLF icon
338
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
-356,745
Closed -$11.8M

Similar funds

Grimes & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Grimes & Company held 338 positions worth $3.02B, up 17% from $2.59B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $190M of net new capital in Q4 2023, opening 35 new positions and adding to 173 existing holdings. Its largest new stake was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $163M trimmed.

  • Grimes & Company's largest Q4 2023 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.
  • Grimes & Company added most to iShares Core MSCI Emerging Markets ETF in Q4 2023, an estimated $83M increase.
  • Grimes & Company's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $163M.
  • Grimes & Company fully exited State Street Financial Select Sector SPDR ETF in Q4 2023, selling an estimated $11.8M.
  • Grimes & Company's ten largest holdings make up 45% of its $3.02B portfolio in Q4 2023.
  • Grimes & Company opened 35 new positions and closed 7 in Q4 2023.
  • Grimes & Company's portfolio value rose 17% quarter-over-quarter to $3.02B.

Based on Grimes & Company's 13F filing for Q4 2023, filed 24 Jan 2024.